Zacks Research Comments on Novavax FY2027 Earnings
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at Zacks Research issued their FY2027 earnings per share (EPS) estimates for shares of Novavax in a research note issued on Thursday, March 20th. Zacks Research analyst S. Ganoria expects that the biopharmaceutical company will post earnings of $0.54 per share for the year. The […]
